UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ONC — BeOne Medicines Ltd.
CIK 861177
NEW YORK, NY
Position in ONC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$608,979
-$25,644 QoQ
Shares Held
2,137
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#144
of 282 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. ONC ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,086,683 | $1,533,248,041 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
716,560 | $446,803,817 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
727,848 | $219,104,078 | |
| 4 | INCY |
Incyte Corp
|
1,508,720 | $171,028,494 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
912,335 | $170,862,094 | |
| 6 | INSM |
INSMED Inc
|
1,335,071 | $142,345,265 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,454,672 | $115,340,938 | |
| 8 | MRNA |
Moderna, Inc.
|
1,521,849 | $106,575,080 |
All Filings in ONC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $608,979 | 2,137 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $634,623 | 2,137 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $418,042 | 1,376 | Shares | Defined | 2026-02-13 | |
| 2025-06-30 | $1,025,407 | 4,236 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,084,868 | 3,986 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $616,192 | 3,336 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $849,993 | 3,786 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $685,813 | 4,807 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $373,614 | 2,389 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $718,913 | 3,986 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $581,518 | 3,233 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $648,654 | 3,638 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $784,097 | 3,638 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,886,271 | 13,123 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $25,766,392 | 191,117 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $30,428,609 | 188,005 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $34,866,670 | 184,871 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $49,179,753 | 181,522 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $65,566,512 | 180,624 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $61,459,149 | 179,082 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $66,488,152 | 191,014 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $48,285,080 | 186,869 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $37,228,891 | 129,971 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $23,749,137 | 126,057 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $15,678,179 | 127,351 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||